Anti-obesity effect of Neoagaro-oligosaccharides with overweight and obese subjects: a 16-week, randomized, double-blind, placebo-controlled clinical trial

BACKGROUND: This trial aimed to evaluate the anti-obesity effects and safety of Neoagaro-oligosaccharides (NAOs) in humans in a 16 week, randomized, double-blind, placebo-controlled clinical trial. METHODS: One hundred overweight or obese subjects with a body mass index of 23 to 34.9 kg/m(2) and a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Baek, Hyang-Im, Ha, Ki-Chan, Park, Yu Kyung, Lee, Je Hyeon, Kim, Eun Joo, Ko, Hye-Jeong, Joo, Jong Cheon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585797/
https://www.ncbi.nlm.nih.gov/pubmed/37858097
http://dx.doi.org/10.1186/s12906-023-04206-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585797/
https://www.ncbi.nlm.nih.gov/pubmed/37858097
http://dx.doi.org/10.1186/s12906-023-04206-2

Ejemplares similares